Cargando…
miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis
Drug resistance, which is closely correlated with an imbalance in apoptosis, endows colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment with therapeutics. We report that miR-15b-5p is a tumor suppressor whose level is globally decreased in CRC cells and tissues....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482850/ https://www.ncbi.nlm.nih.gov/pubmed/28646148 http://dx.doi.org/10.1038/s41598-017-04172-z |
_version_ | 1783245640711536640 |
---|---|
author | Zhao, Ci Zhao, Qi Zhang, Chunhui Wang, Guangyu Yao, Yuanfei Huang, Xiaoyi Zhan, Fei Zhu, Yuanyuan Shi, Jiaqi Chen, Jianan Yan, Feihu Zhang, Yanqiao |
author_facet | Zhao, Ci Zhao, Qi Zhang, Chunhui Wang, Guangyu Yao, Yuanfei Huang, Xiaoyi Zhan, Fei Zhu, Yuanyuan Shi, Jiaqi Chen, Jianan Yan, Feihu Zhang, Yanqiao |
author_sort | Zhao, Ci |
collection | PubMed |
description | Drug resistance, which is closely correlated with an imbalance in apoptosis, endows colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment with therapeutics. We report that miR-15b-5p is a tumor suppressor whose level is globally decreased in CRC cells and tissues. Over-expression of miR-15b-5p not only promoted 5-fluorouracil (5-FU)-induced cellular apoptosis but also reversed the chemoresistance of 5-FU in vitro and in vivo. As a key mediator of inflammation-induced cancer, miR-15b-5p enhances these therapeutic effects are mainly attributed to targeting of the NF-κB signaling pathway through negative regulation of NF-κB1 and one of its kinase complexes IKK-α. miR-15b-5p mediates NF-ĸB regulation by targeting the anti-apoptosis protein XIAP in vitro. Together, these results establish an axis of miR-15b-mediated apoptosis regulation, which reverses chemoresistance and suppresses CRC progression. These findings suggest that miR-15b-5p may be a potential agent for CRC treatment, particularly for 5-FU-resistant CRC. |
format | Online Article Text |
id | pubmed-5482850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54828502017-06-26 miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis Zhao, Ci Zhao, Qi Zhang, Chunhui Wang, Guangyu Yao, Yuanfei Huang, Xiaoyi Zhan, Fei Zhu, Yuanyuan Shi, Jiaqi Chen, Jianan Yan, Feihu Zhang, Yanqiao Sci Rep Article Drug resistance, which is closely correlated with an imbalance in apoptosis, endows colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment with therapeutics. We report that miR-15b-5p is a tumor suppressor whose level is globally decreased in CRC cells and tissues. Over-expression of miR-15b-5p not only promoted 5-fluorouracil (5-FU)-induced cellular apoptosis but also reversed the chemoresistance of 5-FU in vitro and in vivo. As a key mediator of inflammation-induced cancer, miR-15b-5p enhances these therapeutic effects are mainly attributed to targeting of the NF-κB signaling pathway through negative regulation of NF-κB1 and one of its kinase complexes IKK-α. miR-15b-5p mediates NF-ĸB regulation by targeting the anti-apoptosis protein XIAP in vitro. Together, these results establish an axis of miR-15b-mediated apoptosis regulation, which reverses chemoresistance and suppresses CRC progression. These findings suggest that miR-15b-5p may be a potential agent for CRC treatment, particularly for 5-FU-resistant CRC. Nature Publishing Group UK 2017-06-23 /pmc/articles/PMC5482850/ /pubmed/28646148 http://dx.doi.org/10.1038/s41598-017-04172-z Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zhao, Ci Zhao, Qi Zhang, Chunhui Wang, Guangyu Yao, Yuanfei Huang, Xiaoyi Zhan, Fei Zhu, Yuanyuan Shi, Jiaqi Chen, Jianan Yan, Feihu Zhang, Yanqiao miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title | miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title_full | miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title_fullStr | miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title_full_unstemmed | miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title_short | miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis |
title_sort | mir-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the nf-κb/xiap axis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482850/ https://www.ncbi.nlm.nih.gov/pubmed/28646148 http://dx.doi.org/10.1038/s41598-017-04172-z |
work_keys_str_mv | AT zhaoci mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT zhaoqi mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT zhangchunhui mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT wangguangyu mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT yaoyuanfei mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT huangxiaoyi mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT zhanfei mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT zhuyuanyuan mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT shijiaqi mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT chenjianan mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT yanfeihu mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis AT zhangyanqiao mir15b5presensitizescoloncancercellsto5fluorouracilbypromotingapoptosisviathenfkbxiapaxis |